Literature DB >> 7755999

Echocardiographic automatic boundary detection to measure left atrial function after the maze procedure.

M S Feinberg1, A D Waggoner, K M Kater, J L Cox, J E Pérez.   

Abstract

Automatic boundary detection (ABD) is a new echocardiographic modality providing continuous on-line measurements of cavitary area throughout the cardiac cycle. The maze procedure is a new surgical intervention designed to restore sinus rhythm and mechanical atrial contraction as a definitive treatment for patients with atrial fibrillations for whom medical therapy has failed. To evaluate whether ABD may define left atrial function in patients after the maze procedure, we obtained pulsed Doppler recordings of mitral inflow velocity and echocardiographic ABD in 25 patients, 6 +/- 2 months after the maze procedure. We measured the left atrial end-systolic cavitary area, mid-diastolic area before atrial contraction, and end-diastolic area (in square centimeters). Left atrial contraction by Doppler was compared with that derived by ABD in patients who underwent the maze procedure and control subjects (n = 13), both qualitatively and quantitatively (atrial filling fraction vs active atrial contraction [ABD] where atrial contraction (in percent) = (mid-diastolic area - end-diastolic area) x 100/(end-systolic area - end-diastolic area in percent]). Restoration of atrial contraction after the maze procedure was detected by Doppler in 19 patients (76%) and by ABD in 21 patients (84%). The atrial filling fraction was 19 +/- 4% in patients compared with values of 34% +/- 8% in control subjects (p < 0.001). By ABD atrial contraction was 20% +/- 6% in patients whereas control subjects exhibited values of 41% +/- 14% p < 0.001). The Doppler-derived atrial filling fraction and ABD-derived atrial contraction were closely correlated (r = 0.91; p < 0.001; y = 0.59x + 8.6). Thus Doppler techniques complemented by ABD provide direct quantitative indexes of left atrial function throughout the cardiac cycle. Although left atrial contraction and filling are reduced after the maze procedure, left atrial function is restored in most patients with a history of atrial fibrillation, and echocardiographic ABD is a sensitive technique for its detection.

Entities:  

Mesh:

Year:  1995        PMID: 7755999     DOI: 10.1016/s0894-7317(05)80403-1

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

Review 1.  Surgery for atrial fibrillation.

Authors:  J M McComb
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study.

Authors:  K T Spencer; V Mor-Avi; J Gorcsan; A N DeMaria; T R Kimball; M J Monaghan; J E Perez; L Weinert; J Bednarz; K Edelman; O L Kwan; B Glascock; J Hancock; C Baumann; R M Lang
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

3.  Efficacy of Oral Anticoagulation in Stroke Prevention among Sinus-Rhythm Patients Who Lack Left Atrial Mechanical Contraction after Cryoablation.

Authors:  José Martínez-Comendador; Javier Gualis; José Miguel Marcos-Vidal; Jonnatan Buber; Carlos Esteban Martín; Jesús Gomez-Plana; Miguel Angel Rodríguez; Ignacio Iglesias-Garriz; David Alonso; Carlos Soria; Eva Higuera Miguélez; Mario Castaño
Journal:  Tex Heart Inst J       Date:  2015-10-01

4.  The effects of the Cox maze procedure on atrial function.

Authors:  Rochus K Voeller; Andreas Zierer; Shelly C Lall; Shun-ichiro Sakamoto; Nai-Lun Chang; Richard B Schuessler; Marc R Moon; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-06       Impact factor: 5.209

5.  Disturbed Left Atrial Function is Associated with Paroxysmal Atrial Fibrillation in Hypertension.

Authors:  Erhan Tenekecioglu; Fahriye Vatansever Agca; Ozlem Arican Ozluk; Kemal Karaagac; Serafettin Demir; Tezcan Peker; Mustafa Kuzeytemiz; Muhammed Senturk; Mustafa Yilmaz
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.